Your browser doesn't support javascript.
loading
Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation.
Hagiwara, Akifumi; Schlossman, Jacob; Shabani, Soroush; Raymond, Catalina; Tatekawa, Hiroyuki; Abrey, Lauren E; Garcia, Josep; Chinot, Olivier; Saran, Frank; Nishikawa, Ryo; Henriksson, Roger; Mason, Warren P; Wick, Wolfgang; Cloughesy, Timothy F; Ellingson, Benjamin M.
Afiliação
  • Hagiwara A; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Schlossman J; Deptartment of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Shabani S; Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan.
  • Raymond C; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Tatekawa H; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Abrey LE; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Garcia J; Deptartment of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Chinot O; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Saran F; Deptartment of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
  • Nishikawa R; Department of Diagnostic and Interventional Radiology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Henriksson R; F. Hoffman-La Roche, Ltd., Basel, Switzerland.
  • Mason WP; F. Hoffman-La Roche, Ltd., Basel, Switzerland.
  • Wick W; Aix-Marseille University, AP-HM, Service de Neuro-Oncologie, CHU Timone, Marseille, France.
  • Cloughesy TF; The Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Ellingson BM; Saitama Medical University, Saitama, Japan.
J Neurooncol ; 159(3): 509-518, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35842871
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article